Regenxbio Inc (RGNX)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
9.61 +0.20 (+2.13%) 04/30/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 9.61 unch (unch) 16:03 ET
for Wed, Apr 30th, 2025
Results
download Want to compare other data? Select FieldsSymbol | RGNX | MNMD | GHRS | ||
Company | Regenxbio Inc | Mind Medicine Mindmed Inc | Gh Research Plc | ||
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NASDAQ | ||
Open | 9.18 | 6.10 | 8.82 | ||
High | 9.72 | 6.80 | 9.63 | ||
Low | 9.01 | 6.09 | 8.75 | ||
Last | 9.61 | 6.39 | 9.54 | ||
Change | +0.20 | +0.09 | +0.54 | ||
% Change | +2.13% | +1.43% | +6.00% | ||
Volume | 575,300 | 1,902,700 | 228,700 | ||
20-Day Average Volume | 1,050,370 | 1,166,100 | 200,030 | ||
Previous Close | 9.41 | 6.30 | 9.00 | ||
Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
Has Options | Yes | Yes | Yes | ||
Technicals | |||||
20-Day Moving Average | 7.16 | 5.76 | 9.32 | ||
20-Day Raw Stochastic | 97.65% | 80.48% | 51.83% | ||
20-Day Relative Strength | 64.86% | 52.27% | 46.10% | ||
Weighted Alpha | -55.46 | -39.63 | -27.94 | ||
Today's Opinion | 8% Buy | 48% Sell | 8% Sell | ||
Previous Opinion | 8% Sell | 64% Sell | 40% Sell | ||
Last Month's Opinion | 88% Sell | 56% Sell | 48% Buy | ||
Performance | |||||
5-Days | |||||
%Chg | +8.34% since 04/23/25 | +4.58% since 04/23/25 | +0.42% since 04/23/25 | ||
Low | 8.52 on 04/24/25 | 6.09 on 04/30/25 | 8.75 on 04/30/25 | ||
High | 9.72 on 04/30/25 | 6.80 on 04/30/25 | 10.00 on 04/28/25 | ||
1-Month | |||||
%Chg | +22.73% since 03/28/25 | +3.23% since 03/28/25 | -13.74% since 03/28/25 | ||
Low | 5.03 on 04/09/25 | 4.70 on 04/09/25 | 7.98 on 04/09/25 | ||
High | 9.72 on 04/30/25 | 6.80 on 04/30/25 | 11.28 on 03/31/25 | ||
3-Month | |||||
%Chg | +21.65% since 01/30/25 | -10.38% since 01/30/25 | -1.55% since 01/30/25 | ||
Low | 5.03 on 04/09/25 | 4.70 on 04/09/25 | 7.98 on 04/09/25 | ||
High | 9.72 on 04/30/25 | 10.44 on 02/14/25 | 20.50 on 02/03/25 | ||
6-Month | |||||
%Chg | +8.71% since 10/30/24 | +0.79% since 10/30/24 | +14.53% since 10/30/24 | ||
Low | 5.03 on 04/09/25 | 4.70 on 04/09/25 | 6.72 on 12/20/24 | ||
High | 12.22 on 11/11/24 | 10.44 on 02/14/25 | 20.50 on 02/03/25 | ||
Key Statistics | |||||
Market Capitalization, $K | 471,601 | 474,818 | 468,252 | ||
Shares Outstanding, K | 50,117 | 75,368 | 52,028 | ||
Annual Sales | 83,330,000 | 0 | 0 | ||
Annual Net Income | -227,100,000 | -108,680,000 | -38,960,000 | ||
Last Quarter Sales | 21,210,000 | 0 | 0 | ||
Last Quarter Net Income | -51,190,000 | -34,740,000 | -8,800,000 | ||
60-Month Beta | 1.26 | 2.54 | 0.84 | ||
Per-Share Information | |||||
Most Recent Earnings | -1.01 on 03/13/25 | -0.41 on 03/06/25 | -0.17 on 02/27/25 | ||
Latest Earnings Date | 05/14/25 | 05/08/25 | 05/02/25 | ||
Most Recent Dividend | N/A | N/A | N/A | ||
Next Ex-Dividends Date | N/A | N/A | N/A | ||
Ratios | |||||
Price/Earnings ttm | 0.00 | 0.00 | 0.00 |